Title of article :
Age, Body Mass Index, and Number of Previous Trials: Are They Prognosticators of Intra-Uterine-Insemination for Infertility Treatment?
Author/Authors :
Isa، Ahmed M. نويسنده Department of Obstetrics and Gynecology, Assisted Conception Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia , , Abu-Rafea، Basim نويسنده Department of Obstetrics and Gynecology, Assisted Conception Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia , , Alasiri، Saleh A. نويسنده Department of Obstetrics and Gynecology, Assisted Conception Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia , , Binsaleh، Saleh نويسنده Department of Surgery, Division of Urology, College of Medicine, King Saud University, Riyadh, Saudi Arabia , , Ismail، Kareema H. نويسنده Department of Obstetrics and Gynecology, Assisted Conception Unit, College of Medicine, King Saud University, Riyadh, Saudi Arabia , , Vilos، George A. نويسنده ,
Abstract :
Background: To examine whether pregnancy rate (PR) of intrauterine insemination
(IUI) is related to certain demographic factors, such as age and body mass index
(BMI), along with number of IUI cycles performed, a set of infertile Saudi women.
Materials and Methods: During this prospective study (a 24-month period), 301 Saudi
women with infertility underwent IUI in our infertility clinic. We investigated whether
PR is correlated with patient age and BMI, and the number of IUI trials, in order to determine
if they could be used as prognosticators of pregnancy success.
Results: The highest PR was 14.89% for ages 19-25 and the lowest PR was 4.16% for
ages 41-45, indicating no statistically significant difference among PR in all age groups
(p value of 0.225). Also, in terms of BMI, the highest PR was 13.04% for BMI ?35 and
the lowest was 7.84% for BMI of < 25 to 18.5, indicating no significant difference among
different BMI groups (p value of 0.788). One-cycle treatment, as expected, was more
successful (PR=12.84%) than 2-cycle treatment (PR=5.75%), however, 3-5-cycles treatment
still showed encouraging results (PR=17.24%); but the difference did not reach
statistical significance (p value=0.167).
Conclusion: PR after IUI treatment remained approximately 10% from 19 to 40
years of age and declined after 40. Although no significant difference was observed
among different age groups, earlier treatment is still recommended. There was a
positive but not statistically significant correlation between PR and patient’s BMI indicating
that BMI is not a determining factor. There was also no correlation between
PR and number of IUI trials. Patients can thus try as many times as they want before
moving on to in vitro fertilization (IVF) treatment.